Velarion Records
Free. Unsubscribe any time.

Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. filed 38 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 81 transactions and 1,316,107 shares. 38 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Rapport Therapeutics, Inc. 81

Adoption dates in Rapport Therapeutics, Inc. 4

Results prints in Rapport Therapeutics, Inc. 7

Trades before a print in Rapport Therapeutics, Inc. 1

Interval to Rapport Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Rapport Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted on December 12, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.